| Product Name | MF | CAS | Details |
|---|
| Dasatinib analog-1 | 1174416-41-1 | Details |
| ST-148 maleate | C31H40N4O7S | 390803-40-4 | Details |
| Topoisomerase IIα-IN-8 | C15H15FN6O | 1251578-67-2 | Details |
| AJ-76 hydrochloride | C15H24ClNO | 85378-82-1 | Details |
| H-D-Aha-OH hydrochloride | C4H9ClN4O2 | 1858224-26-6 | Details |
| DBCO-PEG2-DBCO | C44H42N4O6 | 2639395-48-3 | Details |
| DIBAC-GGFG-NH2CH2-Dxd | C61H58FN9O12 | 2758875-01-1 | Details |
| Mal-GGG-Bal-NHS ester | C21H26N6O10 | 1193111-65-7 | Details |
| Cy5.5 DBCO | C59H58N4O14S4 | 1857352-95-4 | Details |
| Muscarine tosylate | C9H20NO2·C7H7O3S | 82083-43-0 | Details |
| ATX-0114 | C37H70N2O5S | 2230647-30-8 | Details |
| DBCO-PEG2-NHS ester | C30H31N3O8 | 2585653-12-7 | Details |
| Benzyl DC-81 | C20H20N2O3 | 127810-79-1 | Details |
| 1R-cis-Permethrin | C21H20Cl2O3 | 54774-45-7 | Details |
| AcBut | C12H14O4 | 65623-82-7 | Details |
| Ipflufenoquin | C19H16F3NO2 | 1314008-27-9 | Details |
| UDP-GalNAz disodium | C17H27N6NaO17P2 | 653600-61-4 | Details |
| mRNA-Encapsulating Lipid Excipient 1 | C44H86N2O5S | 2230647-37-5 | Details |
| A12-Iso5-2DC18 | C45H85N3O2 | 2412492-06-7 | Details |
| OF-C4-Deg-Lin | C100H176N4O10 | 2383003-60-7 | Details |
| (1S)-CCR2 antagonist 1 | 1683534-97-5 | Details |
| (S)-Sabutoclax | 1228178-73-1 | Details |
| PC5-VC-PAB-MMAE | 2922216-98-4 | Details |
| Dermatan sulphate sodium | NULL | 54328-33-5 | Details |
| GL67 | C38H70N4O2 | 179075-30-0 | Details |
| DBCO-PEG4-GGFG-Dxd | C72H79FN10O17 | 2694856-51-2 | Details |
| Lipid 10 | C46H85N3O2 | 2430034-02-7 | Details |
| hUP1-IN-1 potassium | C7H7KN2O2 | 118803-30-8 | Details |
| CCR4 antagonist 4 | C24H27Cl2N7O | 668980-17-4 | Details |
| DMTAP | C34H68NO2+ | 197974-74-6 | Details |
| DSPE-PEG5000-Mal ammonium | 474922-22-0 | Details |
| DCOIT | C11H17Cl2NOS | 64359-81-5 | Details |
| 4-Azidobenzyl alcohol | C7H7N3O | 31499-54-4 | Details |
| Luvixasertib hydrochloride | C28H31ClN6O3 | 1610677-37-6 | Details |
| OF-Deg-Lin | C92H160N4O10 | 1853202-95-5 | Details |
| H-(Gly)3-Lys(N3)-OH hydrochloride | C12H22ClN7O5 | 2737202-70-7 | Details |
| USP7-IN-13 | C24H28N4O3 | 2305046-93-7 | Details |
| Necrostatin-1 (inactive control) | C12H11N3OS | 64419-92-7 | Details |
| 15-Azido-pentadecanoic acid | C15H29N3O2 | 118162-46-2 | Details |
| 6-O-Propynyl-2'-deoxyguanosine | C13H15N5O4 | 1640051-47-3 | Details |
| Ulefnersen | 2589926-25-8 | Details |
| Itacnosertib (hydrocholide) | 2409543-84-4 | Details |
| (Rac)-Lisaftoclax | 2651980-10-6 | Details |
| N3-TEMPO | C9H18N4O | 63697-61-0 | Details |
| JWH 080 | C24H23NO2 | 210179-44-5 | Details |
| 11-Azidoundecanoic acid | C11H21N3O2 | 118162-45-1 | Details |
| Ebio1 | C19H14FNO | 339287-36-4 | Details |
| PLK4-IN-4 | C21H23F2N9 | 2923999-01-1 | Details |
| GW405833 hydrochloride | C23H25Cl3N2O3 | 1202865-22-2 | Details |
| PSB-1115 potassium salt | C14H15KN4O5S | 409344-71-4 | Details |
| (S)-Ro 32-0432 | C28H29ClN4O2 | 1781828-85-0 | Details |
| MMAF-OtBu | C43H73N5O8 | 745017-95-2 | Details |
| FAICAR | C10H15N4O9P | 13018-54-7 | Details |
| C24-Ceramide | C42H83NO3 | 34435-05-7 | Details |
| Azidoacetic Acid | C2H3N3O2 | 18523-48-3 | Details |
| Kdo Azide | C8H16N4O7 | 1380099-68-2 | Details |
| Biliverdin | C33H34N4O6 | 114-25-0 | Details |
| NT1-014B | C40H68N2O4S4 | 2739805-64-0 | Details |
| Lipid 15 | 2588111-36-6 | Details |
| BMS-561392 formate | C27H32N4O4.CH2O2 | 2922280-85-9 | Details |
| Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide | 2750623-07-3 | Details |
| Val-Ala-PABC-Exatecan trifluoroacetate | 2928571-45-1 | Details |
| Fmoc-D-Lys(N3)-OH | C21H22N4O4 | 1198791-53-5 | Details |
| Melanin | C18H10N2O4 | 8049-97-6 | Details |
| Biotin-PEG4-MeTz | C31H46N8O7S | 1962919-31-8 | Details |
| Tyrosinase-IN-22 | C7H5ClN2S | 25369-78-2 | Details |
| SOS1 agonist-1 | C26H29BrClFN4O2 | 2245237-61-8 | Details |
| Lipid 8 | C44H82N2O2 | 2226547-25-5 | Details |
| C14-4 | C84H173N5O7 | 2639634-80-1 | Details |
| LU-005i | C31H46N4O7 | 1620107-33-6 | Details |
| SN40 hydrochloride | C18H20N2O2.ClH | 2768663-15-4 | Details |
| Deruxtecan analog 2 monoTFA | C31H31F4N5O9 | 2758874-59-6 | Details |
| Glu-urea-Glu-NHS ester | C27H43N3O11 | 1228927-36-3 | Details |
| PBD dimer-2 | C31H36N4O6 | 145325-57-1 | Details |
| Halo-DBCO | C29H35ClN2O4 | 1808119-16-5 | Details |
| DBCO-PEG24-Maleimide | 2924872-84-2 | Details |
| Veldoreotide TFA | C60H74N12O10.C2HF3O2 | 2126831-23-8 | Details |
| Ionizable lipid-2 | C50H99NO7 | 2763904-72-7 | Details |
| LNP Lipid-7 | C41H74O3 | 1190203-55-4 | Details |
| PH-HG-005-5 | C41H47N7O10 | 2810895-93-1 | Details |
| Infigratinib-Boc | C29H35Cl2N7O5 | 2504949-83-9 | Details |
| N1-Azido-spermine trihydrochloride | C10H25ClN6 | 1823475-98-4 | Details |
| Spermine(N3BBB) | 1190203-80-5 | Details |
| (R)-Vanzacaftor | C32H39N7O4S | 2374124-48-6 | Details |
| (R)-IDO/TDO-IN-1 | 2033173-00-9 | Details |
| Mal-VC-PAB-PNP | C32H37N7O11 | 1096584-62-1 | Details |
| ML 315 hydrochloride | C18H14Cl3N3O2 | 2172559-91-8 | Details |
| MC-Val-Cit-PAB-Ispinesib | C59H71ClN10O10 | 1629737-40-1 | Details |
| PTK7/β-catenin-IN-1 | C22H16N2O2 | 906147-24-8 | Details |
| 8-NH2-ATP tetrasodium | C10H17N6O13P3.4Na | 35892-97-8 | Details |
| Mal-Gly-PAB-Exatecan-D-glucuronic acid | C47H45FN6O17 | 2763252-25-9 | Details |
| HPK1-IN-2 dihydrochloride | C19H21ClN6OS | 2375595-72-3 | Details |
| Pelacarsen sodium | 2172851-58-8 | Details |
| PolQi2 | 2565638-16-4 | Details |
| OSu-PEG4-VC-PAB-MMAE | C74H117N11O21 | 2762518-86-3 | Details |
| γ-CEHC | C15H20O4 | 178167-75-4 | Details |
| 50-C2-C9-4tail | C100H176N4O10 | 1853203-01-6 | Details |
| 4'-Acetyl-chrysomycin B | C29H30O10 | 2673269-86-6 | Details |
| Boc-Val-Dil-Dap-OH | C29H53N3O8 | 1415246-54-6 | Details |
| Product Total： Product Page： | ||||
| 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||